“anacor-pharmaceuticals” Archives

in
Entry Author Date Location
Dermira Commits $135M for Global Rights to Roche Eczema Drug 08/08/17 San Francisco
How Boragen Banked $10M to Develop New Boron-Based Fungicides 03/06/17 Raleigh Durham
The Biotech Roundup: Immunotherapy Ups And Downs, Gene Deals & More 05/20/16 National
Pfizer, Moving on From Allergan, Pays $5.2B For Anacor Pharma 05/16/16 San Francisco
There is a New Clinical Trial of a Novel Drug for African Sleeping Sickness. Who Cares? 07/12/11 National
Fluidigm Completes IPO on 2nd Try, Geron CEO Exits, Amgen Pushes ‘Son of Dmab,’ & More Bay Area Life Sciences News 02/11/11 San Francisco
Anacor Strikes Acne Deal With Medicis 02/10/11 San Francisco
Onyx Takes a Swing at Myeloma, PacBio Hits Haitian Cholera Genome, Sequenta Nabs $13M, & More Bay Area Life Sciences News 12/10/10 San Francisco
How to Raise Money for an Honest-to-God Innovative Biotech Startup: Highlights from Convergence 12/06/10 National
Pearl Therapeutics Beats $3B Lung Drug, Anacor’s Flat IPO, Medtronic Buys Ardian for $800M, & More Bay Area Life Sciences News 12/03/10 San Francisco
Anacor Pharma Prices IPO at $5 a Share, Down from $16 to $18 Forecast 11/24/10 San Francisco
Anacor Pharmaceuticals Obtains $50,000,000 New Financing 01/06/09 San Francisco
Page 1 of 1